Article Text


FRI0116 Hypermobility in sistemic lupus erythematosus
  1. M Guma1,
  2. A Olive1,
  3. J Forcada2,
  4. JC Duró3,
  5. J Roca4,
  6. S Holgado1,
  7. E Casado1,
  8. X Tena1
  1. 1Rheumatology
  2. 2Rheumatology, CAP St. Roc, Badalona
  3. 3Rheumatology, Hospital Del Mar, Barcelona, Spain
  4. 4Epidemiology, Hospital Del Mar


Objectives To investigate hypermobility in patients in systemic lupus erythematosus (SLE).

Methods Setting: University Hospital; 80 patients with SLE (1999 ACR criteria), 90% females and 10% males, mean age 44 ± 16, who regularly attended a specialist SLE clinic were examined. Control group was composed of 280 patients attending a general practitioner office, 70% females and 30% males, mean age 46 ± 19. Joint laxity was measured according to Carter and Beighton criteria (total score 4 or more). A regression analysis was performed (SAS statistical package).

Results Forty-eight% or patients with SLE and 12% of the control group were hypermobile. Regression analysis showed that after adjustment for the age and sex, patients with SLE were more hypermobile (Odds Ratio:5). Neither the clinical and analytical profile nor the use of corticosteroids was related to hipermobility.

Conclusion Patients with SLE are more hypermobile that control group. No clinical or analytical profile is related. Steroids are not related to the presence of hypermobility in patients with SLE.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.